Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
349 GBX | -0.29% | +13.31% | +23.32% |
05:11am | Hutchmed Starts Phase 2/3 Trials for Pancreatic Cancer Drug in China; Shares Rise 3% | MT |
05:01am | Hutchmed Begins Phase 3 Trials for Leukemia Medication in China | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+23.32% | 3.75B | |
+29.98% | 682B | |
+31.81% | 586B | |
-3.52% | 364B | |
+18.59% | 327B | |
+4.07% | 285B | |
+16.53% | 240B | |
+9.44% | 209B | |
-8.88% | 203B | |
+7.09% | 165B |
- Stock Market
- Equities
- HCM Stock
- News HUTCHMED (China) Limited
- Transcript : HUTCHMED Limited Presents at Deutsche Bank American Depositary Receipt Virtual Investor Conference, Nov-17-2021 08